Mometazonfuroat Cipla 50 mikrograma po potisku sprej za nos, suspenzija
Name | Mometazonfuroat Cipla 50 mikrograma po potisku sprej za nos, suspenzija |
---|---|
Marketing Authorisation Number | HR-H-200034872 |
Active Substance | mometazonfuroat hidrat |
Composition | svaki potisak oslobađa 50 mikrograma mometazonfuroata (u obliku hidrata) kao isporučenu dozu (po potisku) |
Pharmaceutical Form | sprej za nos, suspenzija |
Manufacturer | S&D Pharma CZ, spol. s r.o, Pchery (Pharmos a.s. facility), Češka Orion Corporation, Orion Pharma, Espoo, Finska Cipla Europe NV, Antwerpen, Belgija Orion Corporation, Orion Pharma, Salo, Finska |
Marketing Authorisation Holder | Cipla Europe NV, De Keyserlei 58-60, Box-19, Antwerpen, Belgija |
Marketing Authorisation Date | 05.07.2019 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/18-02/227 |
Registration Number | 381-12-01/70-19-03 |
Prescription | na recept |
Type of prescription | ponovljivi recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | R01AD09 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |
Public Assessment Report | download |